Bryan Kim, MD
Retina Specialist · Des Plaines, ILNPI 1326215039
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,740 of the $7,652 with a category attached, or 61.9%. Eyepoint US, Inc. accounts for 68.2% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2024 at $2,322 and has fallen 82.2% since, to $414 in 2025.
Across 102 payments — averaging $75.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eyepoint US, Inc.$5K
- Regeneron Healthcare Solutions, Inc.$608
- AbbVie$400
- Genentech USA, Inc.$374
- Apellis Pharmaceuticals, Inc.$213
- Alimera Sciences, Inc.$189
- plus $649 from 9 others
What the payments were for
- Consulting fees$4,74062%
- Food & beverage$2,82437%
- Education$881%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eyepoint US, Inc. | 11 | $5,219 |
| Regeneron Healthcare Solutions, Inc. | 16 | $608 |
| AbbVie(2 entities) | 20 | $400 |
| Genentech USA, Inc. | 13 | $374 |
| Apellis Pharmaceuticals, Inc. | 7 | $213 |
| Alimera Sciences, Inc. | 7 | $189 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 5 | $170 |
| ANI Pharmaceuticals, Inc. | 4 | $123 |
| Mallinckrodt Hospital Products Inc. | 6 | $117 |
| Novartis | 4 | $63 |
| Mallinckrodt Enterprises LLC | 3 | $53 |
| Spark Therapeutics, Inc. | 2 | $42 |
| Bausch & Lomb Americas Inc. | 2 | $39 |
| Coherus Oncology, Inc. | 1 | $23 |
| Carl Zeiss Meditec USA, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,652 in reported general payments places this provider in the 70th percentile of 70 retina specialist providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 17 | $8,929 |
| Azelastine Hcl | 187 | $4,478 |
| Prednisolone Acetate | 99 | $4,159 |
| Ketorolac Tromethamine | 209 | $3,034 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 123 | $1,903 |
| Latanoprost | 145 | $1,671 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 129 | $1,326 |
| Brimonidine Tartrate | 38 | $1,240 |
| ErythromycinErythromycin Base | 92 | $893 |
| Diclofenac Sodium | 64 | $608 |
| Timolol Maleate | 39 | $318 |
| Dorzolamide Hcl | 12 | $180 |
| Ofloxacin | 12 | $138 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLumigan | $400 | $8,92917 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 70 retina specialist providers in Illinois.
Other retina specialist in Des Plaines
- Kyle BlairDes Plaines$5K
- Saira KhannaDes Plaines$5K
- Anand GopalDes Plaines$2K
- George WyhinnyDes Plaines$2K
- Enrique Garcia-ValenzuelaDes Plaines$2K
- Daniel AlterDes Plaines$2K
- Michael BlairDes Plaines$927
- Robert GaroonDes Plaines$515
- Mathew MaccumberHarvey$219K
- Rahul KomatiChicago$143K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.